LIFECORE BIOMEDICAL, INC. License Costs (Deprecated 2018-01-31)
LIFECORE BIOMEDICAL, INC. (LFCR) reported License Costs (Deprecated 2018-01-31) of $106.00 thousand for the 3-month period ending 2015-08-30, per its 10-Q filed 2015-10-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LicenseCosts · last filed 2015-10-01
- LIFECORE BIOMEDICAL, INC. license costs (deprecated 2018-01-31) for the quarter ending 2015-08-30 was $106.00K.
- LIFECORE BIOMEDICAL, INC. license costs (deprecated 2018-01-31) for the quarter ending 2014-08-31 was $0.00.
| Period end | License Costs (Deprecated 2018-01-31) 3 month |
|---|---|
| 2015-08-30 | $106.00K 10-Q · filed 2015-10-01 |
| 2014-08-31 | $0.00 10-Q · filed 2015-10-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |